The capacity of Mycoplasma fermentans-derived high-molecular-weight material (MDHM) to generate cytolytic T cells from mitogen-stimulated murine thymocytes was studied in detail. The role of MDHM and the involvement of monokines and lymphokines resulting from the addition of MDHM to thymocyte cultures were examined in complete and adherent cell-depleted culture systems by the addition of neutralizing monoclonal antibodies against interleukin-2 (IL-2), IL-4, and IL-6 and in reconstitution experiments with recombinant mediators. The data presented here suggest that MDHM is crucial only in the first phase of a reaction sequence beginning with the stimulation of adherent accessory cells and resulting in the synthesis of IL-1 and IL-6. The lymphokines IL-2 and, primarily, IL-4 are required in a second step which, once these lymphokines are formed, can proceed in the absence of MDHM and accessory cells and leads to the formation of cytolytic T cells. The elucidation of the MDHM-induced reaction sequence may be of relevance in view of the hypothetical role of mycoplasmas in rheumatic disease in humans. M. fermentans is an organism capable of infecting humans and in an early report has been discussed as a causative agent for rheumatoid arthritis.
Several mycoplasmal products derived from different strains have been proposed to modulate immune cells in a number of ways. MAS, a product from Mycoplasma arthritidis, stimulates lymphocyte proliferation (1) and gamma interferon production (12) . Acholeplasma spp. (25) and membranes from Spiroplasma spp. (23) stimulate tumor necrosis factor alpha synthesis, and membranes from M. arginini or M. arthritidis induce granulocyte-macrophage colony-stimulating factor-dependent macrophage proliferation (24) .
In a previous publication, we described high-molecularweight material from M. fermentans (MDHM) that induces the in vitro release of interleukin-6 (IL-6) from human monocytes and murine peritoneal macrophages (20) . In concanavalin A (ConA)-stimulated thymocyte cultures, MDHM causes the formation of cytolytic T lymphocytes (CTLs). Since neutralizing monoclonal antibodies (MAbs) to IL-6 abolish this effect, we ascribed the MDHM activity in this system to its potential to generate (20) .
In this study, we explored the CTL-inducing capacity of MDHM in more detail. The question as to which mediators are required to allow CTL formation, although studied in many laboratories under different experimental conditions, is still not unequivocally answered. Of the known lymphokines, IL-1 (6, 21) , IL-2 (5, 6), IL-4 (19, 31) , IL-5 (27) , IL-6 (18, 21, 26) , , tumor necrosis factor (30) , and gamma interferon (6, 26) have been implicated at one time or another, either singly or in combination. We wished to identify the relevant mediators involved and clarify the sequence of events which follow the MDHM-mediated formation of CTLs in ConA-stimulated murine thymocyte cultures. Our data suggest that MDHM has a primary function in stimulating the synthesis of IL-1 and IL-6 by * Corresponding author. adherent accessory cells and that IL-2 and, primarily, IL-4 are required for CTL formation in a second step which, once these lymphokines are formed, can proceed in the absence of MDHM and accessory cells.
MATERIALS AND METHODS
Cultivation of M. fermentans. M. fermentans D15-86 was originally isolated from a contaminated human cell line (20) . Mycoplasmas were grown in GBF-1 medium for 3 days at 37°C in an atmosphere containing 5% CO2. GBF-1 medium consists of RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and 10% (vol/vol) cell sonicate. To prepare the sonicate, we suspended P815 mastocytoma cells at 107/ml in phosphate-buffered saline (PBS) and sonicated them in an ice bath by two 2-min bursts in a Branson Sonifier equipped with a conical tip. Cell debris was removed by 45 min of centrifugation at 21,000 x g, and the nonsedimented sonicate was passed through a 0.22-R,m-pore-size sterile filter. GBF-1 medium was, in contrast to conventional mycoplasma media, nontoxic for thymocytes. It was also free of contaminating endotoxin (<10 pg/ml, as determined by the Limulus assay) and showed no activity in the lectin-dependent killing assay.
Preparation of MDHM. Two different preparations were used in this study. MDHM-A was prepared from culture media of HL60 cells infected with M. fermentans D15-86 by ammonium sulfate precipitation (90% saturation), dialysis of the redissolved precipitate against PBS, removal of insoluble material by centrifugation for 1 h at 21,000 x g, and filter sterilization as described previously (20) . MDHM U/,g) was produced and purified in our institute as described previously (7). IL-2 units are defined by the biological response modifier program as described previously (7). Recombinant murine IL-4 (2 x 104 U/,ug) was either affinity purified from the culture medium of a transfected cell line (22) or purchased from Genzyme. IL-4 units are defined by the supplier. Human recombinant IL-1 (rIL-1)
(1.25 x 105 U/,g) was purchased from Genzyme. Activity units are defined as described previously (8) . Human rIL-6
(105 U/,ug) was obtained from Boehringer, Mannheim, Germany. Activity units are defined as described previously (28) . Mitomycin-poisoned spleen accessory cells. Single-cell suspensions were prepared by teasing minced spleen tissue in Hanks balanced salt solution buffered with 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (pH 7.4) (BSS) through a nylon sieve. Cells were adjusted to 5 x 106/ml in RPMI 1640 medium with 5% FCS and 25 pug of mitomycin per ml. Mitomycin was removed after 30 min of incubation at 37°C by washing the cells three times in medium.
Cell culturing, proliferation, and lectin-dependent killing assay. Thymocytes from mice at the age ofS to 7 weeks were prepared in BSS by gentle teasing of thymus tissue through a nylon sieve. For removal of adherent accessory cells, single cells were adjusted to 108/ml in BSS-5% FCS and passed over a 20-ml Sephadex G10 column containing this buffer. Depleted or untreated thymocytes were washed and suspended in RPMI 1640 medium containing 5% FCS, 2 mM glutamine, and 2.5 x 10-' M 2-mercaptoethanol. Cell culturing was performed in this medium at a final cell concentration of 1.5 x 106/ml or 2 x 106/ml in the presence of 4,ug of ConA per ml, and accessory cells, MDHM, mediators, or MAbs were added. Thymocytes were cultured either in 1-ml volumes in Falcon tubes or in 0.2-ml volumes in roundbottom microtiter plate wells. After 3 days of culturing at 37°C in a moist atmosphere containing 7.5% CO2, lectindependent killing was measured in the microtiter cultures by removing 100,ul of culture supematant and replacing it with 100 RI of medium with 104 phytohemagglutinin-coated (5 ,ug/ml), 51Cr-labelled P815 mastocytoma cells. 51Cr release was determined after 4 h of incubation, and specific lysis was [3H]thymidine, which was adjusted with unlabelled thymidine to a final concentration of 20 puM. Thymidine incorporation was determined after 6 h with an automatic cell harvester (Scatron). For the determination of cytolytic activity at different effector-to-target (E/T) ratios, 100-,u serial dilutions of effector cells were added to 104 5"Cr-labelled, phytohemagglutinin-coated P815 target cells in round-bottom microtiter plate wells and specific lysis was determined as described above.
Bioassay of IL-6. IL-6 was determined with hybridoma cell line 7TD1 as described previously (28) .
Immunofluorescence and flow cytometry analysis. Thymocytes were cultured for 3 days under the same conditions as those described for CTL generation. Thirty minutes before harvesting of the cells for immunophenotyping, methyl-cx-Dmannopyranoside (Sigma) was added to a final concentration of 11 mM. The immunophenotypes were determined by a double staining procedure. Cells were labelled in a first step with CD4 (rat IgG; anti-L3T4; clone GK1.5) and CD8 (mouse IgG; anti-Lyt-2.1; NEN, Dreieich, Germany) MAbs. Binding of MAbs was assessed with fluorescein-conjugated rabbit anti-rat IgG antiserum (Medac, Hamburg, Germany) in a second staining step and phycoerythin-conjugated goat anti-mouse IgG antiserum (Southern Biotechnology, Birmingham, Ala.) in a third staining step. The expression of Thy-1.2 was determined with the appropriate MAb (rat IgG; Becton Dickinson, Heidelberg, Germany) and fluoresceinconjugated rabbit anti-rat IgG antiserum. The distribution of antigens was analyzed by flow cytometry (FACScan; Becton Dickinson). The addition of propidium iodide (10 ptg/ml) to cells prior to analysis allowed gating out of dead cells. RESULTS 
MDHM induces CTLs and an increase in CD8+ cells in
ConA-stimulated thymocyte cultures. The assay system used here was originally developed in our laboratory to detect lymphokines that would induce the in vitro differentiation of CTL precursors (CTL-P) to CTLs. Conditions for ConAstimulated thymocyte cultures were chosen such that only Cytolytic activity was determined after 3 (Fig. 3) .
Response of adherent cell-depleted thymocytes to MDHM the adhesion process are a source of monokines, these results suggested that monokines might be a limiting component in the adherent cell-depleted thymocyte system. MDHM might thus act in untreated thymocyte cultures by stimulating'monokine production of a few adherent cells or in reconstituted thymocyte cultures by stimulating monokine production of macrophages added with spleen or peritoneal cells to the adherent cell-depleted cultures.
Response to MDHM involves monokines. If our assumption is correct that the effects of MDHM on CTL formation from thymocytes are indirect and caused by monokines released from adherent accessory cells, MDHM action should be inhibitable by neutralizing MAbs against such monokines. MAbs against murine IL-6 did indeed abolish MDHM action, as previously published (20) and shown in Fig. 4 . In further support of this assumption, the addition of a combination of rIL-1 and rIL-6 to adherent cell-depleted thymocytes led to extensive CTL formation, whereas the addition of each monokine alone was less efficient (Fig. 5) . Lower concentrations of rIL-1 (20 U/ml) only gave rise to a proliferative response (data not shown). Assays for rIL-6 in the supernatants of MDHM-containing, ConA-stimulated thymocyte cultures repeatedly revealed titers of up to 160 U/ml, whereas in control cultures without MDHM, IL-6 activities of between 8 and 32 U/ml were found.
MDHM and monokine effects on thymocytes involve IL-2 and IL-4. Since both IL-2 and IL-4 could lead to CTL formation in our adherent cell-depleted, ConA-stimulated thymocyte cultures (Fig. 2) , the question arose as to whether IL-1 and IL-6 had an indirect effect on CTL formation by acting primarily on helper T cells and giving rise to IL-2, IL-4, or both, which are then required for CTL-P to proliferate and differentiate into CTL effector cells. The addition of a neutralizing MAb against IL-4 to either MDHM-or monokine-stimulated thymocytes inhibited most CTL formation without having much effect on the proliferative activity of the cultures (Fig. 3 and 5, respectively) . In the experiment shown in Fig. 4 , there was consistent inhibition of CTL formation by anti-IL-4 MAbs but an increase in thymidine uptake. It is possible that proliferation, which is normally maximal before the third day of culturing, was delayed in this case and was therefore comparatively higher than in the uninhibited control. These data suggest a primary role for IL-4 in the formation of CTLs under these conditions. However, IL-2 also appears to be required, as neutralizing anti-IL-2 MAbs abolished MDHM-driven CTL formation equally well (Fig. 6) . Surprisingly, we were unable to detect IL-2 or IL-4 in the culture supernatants of MDHMcontaining, ConA-stimulated thymocytes, although many workers, including ourselves (4), have shown that thymocytes can liberate IL-2, albeit under different conditions. However, the frequency of IL-4-producing cells, as determined in an Elispot assay (22) , increased from 1 in 12,000 to 1 in 6,000 upon the addition of IL-6 to the cultures (21a), suggesting a role for this monokine in IL-4 production.
Addition of IL-2 or IL-4 can overcome the inhibition of the effects of MDHM by anti-IL-6 MAbs. The experiment described in the preceding section suggests a dual requirement for IL-2 and IL-4, but it does not exclude 'IL-6 as an additional prerequisite for CTL development, in particular since anti-IL-6 MAbs inhibited CTL formation in our assay (Fig. 4) . If IL-6, in conjunction with lymphokines, were directly required for CTL development rather than for the generation of these lymphokines by helper T cells, then one should not be able to overcome the MAb-mediated inhibition of IL-6 by the addition of lymphokines. We had previously demonstrated that such inhibition could be overcome by and found in this study (Fig. 4) that it could be counteracted equally well by rIL-4. Similarly, rIL-4 was able to abolish the inhibitory action of neutralizing anti-IL-2 MAbs (Fig. 6 ). This result suggests that both IL-4 and IL-2 are limiting factors for the development of CTLs in this system. Fig. 3 . Human rIL-1 (100 U/ml), human rIL-6 (1,000 U/ml), or anti-IL-4 MAbs were added as indicated. Proliferative and cytolytic activities were determined as described in the legend to Fig. 3 Thymocytes depleted of adherent cells lost responsiveness to MDHM but still responded to IL-2 or IL-4 by CTL formation (Fig. 2) . The response to MDHM could be reconstituted by the addition of mitomycin-poisoned spleen cells (Fig. 3) or peritoneal macrophages. This result suggested that MDHM acts on adherent accessory cells, presumably but not necessarily macrophages (16) , reacting to MDHM by monokine synthesis. Indeed, increased IL-6 was measured in MDHM-stimulated thymocyte cultures, and MDHM-mediated CTL formation was reduced to control levels by neutralizing anti-IL-6 MAbs (Fig. 4) (20) . In keeping with this hypothesis are the findings that rIL-1, rIL-6 and, in particular, a combination of both monokines were capable of causing a CTL response in adherent cell-depleted thymocyte cultures (Fig. 5) (30) and that these monokines were synthesized in MDHM-stimulated macrophage cultures (14a, 20) . We regard these monokines as early mediators in this system which are primarily required for the formation of lymphokines but not for CTL differentiation or generation of lymphokine receptors on CTL-P, because the inhibitory action of anti-IL-6 MAbs could be overcome by IL-2 (20) as well as by rIL-4 ( Fig. 4) and both IL-2 and rIL-4 could lead to CTLs in the absence of adherent accessory cells (Fig. 2) . In agreement with a key role for IL-4 is the finding that neutralizing anti-IL-4 MAbs inhibited the effects of MDHM (Fig. 3 and 6 ) as well as those of the monokines (Fig. 5) on CTL formation. However, IL-2 was found to be equally limiting, as anti-IL-2 MAbs also inhibited the effects of MDHM (Fig. 6 ). According to a recent paper, IL-2 is required for IL-4 production (2). In agreement with these findings, inhibition of CTL formation by anti-IL-2 MAbs could be overcome by rIL-4 (Fig. 6) .
A recent publication reported that IL-7 can support the generation of CTLs from thymocytes (3) . Two points argue against the involvement of IL-7 in MDHM-mediated CTL formation. (i) Neither macrophages nor spleen cells are known producers of IL-7, yet both were particularly potent in restoring the MDHM response in adherent cell-depleted thymocyte cultures. (ii) Anti-IL-4 MAbs inhibited the effects of MDHM but not those of IL-7 on CTL formation (3).
Our data are compatible with the following sequence of events resulting from MDHM stimulation. MDHM, added to thymocyte cultures, leads to the synthesis of IL-1 and IL-6 by adherent accessory cells. These monokines are early mediators required for ensuing IL-2 and IL-4 synthesis. Our experiments do not clearly distinguish between a direct requirement of IL-2 for CTL differentiation and an indirect effect of IL-2 on helper T cells resulting in IL-4 synthesis. MAb-containing ascites, or 1,000 U of murine rIL-4 per ml was added. Proliferative and cytolytic activities were determined as described in the legend to Fig. 3 . Data are means t ranges for duplicate determinations at an E/T ratio of 10.
They suggest, however, that IL-4 may be responsible for the final step in MDHM-mediated CTL differentiation.
The elucidation of the MDHM-induced reaction sequence leading to CTLs as a result of monokine liberation may be of relevance in view of the hypothetical role of mycoplasmas in rheumatic disease. M. fermentans is an organism capable of infecting humans and, in an earlier report, was discussed as a causative agent for rheumatoid arthritis (32) . Activated CD8+ T cells have in fact been detected in synovial fluid in cases of reactive arthritis (15) , and increased levels of IL-1 (10) and IL-6 (9, 11) have been measured in synovial fluid in rheumatoid arthritis patients.
